Brain Hypothermia Therapy and Targeted Temperature Management for Acute Encephalopathy in Children: Status and...

Area of Science:

• Pediatric Neurology
• Critical Care Medicine
• Neuroscience

Background:

• Brain hypothermia therapy (BHT) is established for neuroprotection in adults post-cardiac arrest.
• Neonatal cryotherapy is used for hypoxic-ischemic encephalopathy (HIE), recommended for severe cases.
• The potential of BHT for pediatric neuroprotection, particularly in acute encephalopathy, is recognized but lacks clinical validation.

Purpose of the Study:

• To review the pathogenesis of neuronal damage in hypoxic/hypoperfused brains.
• To explore the history, effects, mechanisms, and methods of BHT.
• To discuss the development of BHT and targeted temperature management for pediatric acute encephalopathy.

Main Methods:

• Literature review of BHT and targeted temperature management.
• Analysis of pathogenesis of neuronal injury in hypoxic and hypoperfused brains.
• Examination of BHT's history, effects, mechanisms, cooling/monitoring methods, and adverse reactions.

Main Results:

• BHT is effective in adult neuroprotection but lacks clinical evidence in pediatric acute encephalopathy.
• Pathophysiology of HIE in neonates differs from adult post-cardiac arrest scenarios.
• No international collaborative studies or robust clinical evidence support BHT for pediatric neuroprotection.

Conclusions:

• While theoretically promising, BHT faces significant limitations for clinical use in pediatric acute encephalopathy.
• Further research, including international collaborative studies, is crucial to establish BHT's efficacy and safety in children.
• Targeted temperature management principles may inform future BHT development for pediatric applications.